„Genome editing“
Suchergebnisse
1.000+ Treffer
-
Synthetic Biology, Genome Editing, and the Risk of Bioterrorism
-
Generation of ΔF508-CFTR T84 cell lines by CRISPR/Cas9-mediated genome editing
-
CRISPR/Cas9‐mediated genome engineering: An adeno‐associated viral (AAV) vector toolbox
-
Genome Editing Reveals Novel Thiotemplated Assembly of Polythioamide Antibiotics in Anaerobic Bacteria
-
Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system
-
CRISPR/Cas9 genome editing – new and old ethical issues arising from a revolutionary technology
-
Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome
-
Therapeutic Glypican‐3 CRISPR Genome‐Editing Using UltraLarge Porous Silica Nano‐Depot for the Treatment of Hepatocellular Carcinoma
-
Genome Editing VEGFA Prevents Corneal Neovascularization In Vivo (Adv. Sci. 25/2024)
-
A T‐Cell Inspired Sonoporation System Enhances Low‐Dose X‐Ray‐Mediated Pyroptosis and Radioimmunotherapy Efficacy by Restoring Gasdermin‐E Expression (Adv. Mater. 26/2024)
-
Cover Picture: Self‐Assembled DNA Nanoclews for the Efficient Delivery of CRISPR–Cas9 for Genome Editing (Angew. Chem. Int. Ed. 41/2015)
-
Titelbild: Self‐Assembled DNA Nanoclews for the Efficient Delivery of CRISPR–Cas9 for Genome Editing (Angew. Chem. 41/2015)
-
Microfluidic Techniques for Next‐Generation Organoid Systems (Adv. Mater. Interfaces 29/2022)
-
Genome Editing in Animals – Methods and Protocols
-
Efficient genome editing of differentiated renal epithelial cells
-
In Vitro Mutagenesis – Methods and Protocols
-
Protein Delivery: Intracellular Delivery of His‐Tagged Genome‐Editing Proteins Enabled by Nitrilotriacetic Acid–Containing Lipidoid Nanoparticles (Adv. Healthcare Mater. 6/2019)
-
Magnetic‐Activated Nanosystem with Liver‐Specific CRISPR Nonviral Vector to Achieve Spatiotemporal Liver Genome Editing as Hepatitis B Therapeutics (Adv. Funct. Mater. 7/2023)
-
Intracellular Delivery: A Comprehensive Review on Intracellular Delivery (Adv. Mater. 13/2021)
-
Cancer Immunotherapy: Reprogramming the Tumor Microenvironment through Second‐Near‐Infrared‐Window Photothermal Genome Editing of PD‐L1 Mediated by Supramolecular Gold Nanorods for Enhanced Cancer Immunotherapy (Adv. Mater. 12/2021)